Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells
Open accessThe DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Abstract
The burden of chronic liver disease is globally increasing at an alarming rate. Chronic liver injury leads to liver inflammation and fibrosis (LF) as critical determinants of long-term outcomes such as cirrhosis, liver cancer, and mortality. LF is a wound-healing process characterized by excessive deposition of extracellular matrix (ECM) proteins due to the activation of hepatic stellate cells (HSCs). In the healthy liver, quiescent HSCs metabolize and store retinoids. Upon fibrogenic activation, quiescent HSCs transdifferentiate into myofibroblasts; lose their vitamin A; upregulate α-smooth muscle actin; and produce proinflammatory soluble mediators, collagens, and inhibitors of ECM degradation. Activated HSCs are the main effector cells during hepatic fibrogenesis. In addition, the accumulation and activation of profibrogenic macrophages in response to hepatocyte death play a critical role in the initiation of HSC activation and survival. The main source of myofibroblasts is resident HSCs. Activated HSCs migrate to the site of active fibrogenesis to initiate the formation of a fibrous scar. Single-cell technologies revealed that quiescent HSCs are highly homogenous, while activated HSCs/myofibroblasts are much more heterogeneous. The complex process of inflammation results from the response of various hepatic cells to hepatocellular death and inflammatory signals related to intrahepatic injury pathways or extrahepatic mediators. Inflammatory processes modulate fibrogenesis by activating HSCs and, in turn, drive immune mechanisms via cytokines and chemokines. Increasing evidence also suggests that cellular stress responses contribute to fibrogenesis. Recent data demonstrated that LF can revert even at advanced stages of cirrhosis if the underlying cause is eliminated, which inhibits the inflammatory and profibrogenic cells. However, despite numerous clinical studies on plausible drug candidates, an approved antifibrotic therapy still remains elusive. This state-of-the-art review presents cellular and molecular mechanisms involved in hepatic fibrogenesis and its resolution, as well as comprehensively discusses the drivers linking liver injury to chronic liver inflammation and LF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Molecular pathways and cellular interactions involved in HSC activation and deactivation. Activated HSCs are the main effector cells during hepatic fibrosis. In the healthy liver, they metabolize and store retinoids. Upon activation by fibrogenic stimuli, quiescent HSCs transdifferentiate into myofibroblasts, lose their vitamin A, upregulate α-smooth muscle actin (αSMA), and produce collagen I. Various factors, including immune cell-derived fibrogenic molecules, growth factors, and lipopolysaccharide, as well as profibrotic lipid mediators such as lysophosphatidylinositol and lysophosphatidic acid, induce HSC activation in the course of chronic liver disease. TGF-β is the most HSC potent activator, which is produced by infiltrating lymphocytes and monocytes, Kupffer cells (KCs), and damaged hepatocytes. IL-17, produced by neutrophils and Th17 cells, sensitizes HSCs to TGF-β by upregulating TGF-β receptor II (TGF-βRII). In addition, platelet-derived growth factor (PDGF), which is produced by endothelial cells and macrophages, further promotes HSC activation. During fibrosis resolution, HSCs either die or revert to an inactive state by upregulating transcription factors such as peroxisome proliferator-activated receptor-γ (PPARγ), GATA-binding factor 4 (GATA4), GATA6, and transcription factor 21 (TCF21). NK and CD8+ T cells can eliminate activated HSCs by inducing apoptosis (Further abbreviations: GM-CSF, granulocyte/macrophage colony-stimulating factor; HH, hedgehog ligands; IHH, Indian Hedgehog; LPA, lysophosphatidic acid; LPI, lysophosphatidylinositol; LPS, lipopolysaccharide; miRNA, microRNA; MSR1, macrophage scavenger receptor 1; NF-κB, nuclear factor κ-light chain-enhancer of activated B cells; OPN, osteopontin; oxLDL, oxidized low-density lipoprotein; ROS, reactive oxygen species; S1P, sphingosine-1-phosphate; SHH, sonic hedgehog; TLR4, Toll-like receptor 4). Modified from reference [5].](https://figures.cochat.ai/paper-figures/ba56d748dfcc4395a6907c0c93306af8/liver-fibrosis-from-basic-science-towards-clinical-progress-focusing-on-the-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A pivotal element in acute and chronic liver damage is hepatic stellate cells (HSCs) activation. In response to hepatocyte injury, HSCs transition into activated myofibroblasts, overproducing extracellular matrix components and driving fibrosis (Akkız H, 2024).”
From A 3D bioengineered human liver for the study of acute and chronic drug-induced hepatotoxicity and fibrosis (2026) · cites this paper as Akkız H, 2024
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268 · cited 2×
“Neutrophils are critical first responders of the innate immune system, and they can contribute to hepatic inflammation by producing proinflammatory cytokines and neutrophil extracellular traps (NETs), activating KCs, and recruiting additional types of immune cells [60–62].”
BackgroundMechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · cited 1×
“…factor, liver fibrosis reverts, going along with the decreased production of proinflammatory and profibrogenic cytokines, upregulated collagenolytic activity, the disappearance of fibrogenic cells, decreased ECM production, and, eventually, the dissolution of the fibrosis scar [1,2,4,5,13–17].”
BackgroundTGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380 · cited 3×
“Senescent HSCs are α -SMA-positive cells, but they neither proliferate nor produce collagen [2,5,10,11].”
BackgroundVilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · cited 1×
“In contrast, successful antiviral treatment in patients with chronic viral hepatitis or with considerable lifestyle changes in NASH patients modulate the resolution of fibrosis [6–9].”
BackgroundInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“ILCs, particularly ILC1s and ILC3s, are involved in liver fibrogenesis [82,83].”
BackgroundMolecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024 · cited 10×
“…accumulation of bone marrow-derived inflammatory immune cells, secretion of proinflammatory cytokines, production of TGF-β by profibrogenic macrophages, activation of collagen type I (COLIAI)-secreting hepatic myofibroblasts, excessive production of the ECM, and the formation of a fibrous scar [4].”
BackgroundInfluentialAlcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963 · cited 1×
“In mice, the elimination of neutrophils or the deletion of neutrophil-derived soluble molecules (IL-8, IL-18, IL-17, CCL3, CCl 4 , and CCL2) attenuates the development of hepatic fibrosis [63,64].”
BackgroundTLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942 · cited 1×
“Blocking TLR4 signaling in mice or reducing hepatic exposure to intestinal microorganisms improves liver fibrosis [81].”
BackgroundFibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868 · cited 10×
“The combination of low extracellular pH with an increased lactic acid level promotes myofibroblast transformation through the activation of TGF-β 1 [1,144–146].”
BackgroundInfluentialPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
The interaction between bacteria and bile
Begley, M., Gahan, C. G. M., & Hill, C. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.09.003 · Cited by 1,790 · cited 1×
“In addition, dysfunctional gut permeability enables PAMPs and DAMPs to enter the liver where they activate immune cells and engage with hepatic Toll-like receptors (TLRs) to induce proinflammatory and fibrotic pathways [97,98].”
BackgroundMarcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Non-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“Another study in mouse models of liver fibrosis demonstrated that the resolution is delayed by KC depletion and accelerated by an adoptive transfer of KCs from wild-type animals, compared to KCs from MMP9 –/– mice, suggesting that KC-derived MMP9 is essential in resolving fibrosis [207].”
BackgroundLNCcation: lncRNA localization and function
Bridges, M. C., Daulagala, A. C., & Kourtidis, A. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202009045 · Cited by 1,556
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443 · cited 1×
“This process results in the recruitment of endothelial cells, blood vessel growth, and activation of Kupffer cells (KCs) and myofibroblasts to reestablish the ECM, all of which enable the progression of wound healing [2,4,18].”
BackgroundLiver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · cited 1×
“KCs are the major cell population of the innate immune system; this particular cell population is able to sense hepatocyte stress and injury signals from other cells, as well as to engulf cellular debris and release inflammatory signals [5,73].”
BackgroundFrom NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392 · cited 1×
“The gut permeability defect leads to the translocation of microbial products such as LPS, which elevates their serum levels and promotes the proinflammatory response elicited by hepatic macrophages [96].”
BackgroundLipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.054 · Cited by 1,377 · cited 3×
“During the progression of fibrosis, inflammation accelerates macrophage trafficking and promotes their accumulation in the liver, where these cells express cytokines and chemokines that stimulate HSC activation [88].”
BackgroundInfluentialMyofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310 · cited 1×
“They display high phenotypic and functional diversity and plasticity, which means that they change their transcriptional profiles and functions based on environmental, tissue-associated, and inflammatory stimuli [5,70–72].”
BackgroundSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 6×
“The authors suggested that HSCs are deactivated in the healing liver [193].”
BackgroundMethodInfluentialNLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Mridha, A. R., Wree, A., Robertson, A. A. B., Yeh, M. M., Johnson, C. D., Van Rooyen, D. M., Haczeyni, F., Teoh, N. C.-H., Savard, C., Ioannou, G. N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.022 · Cited by 1,110 · cited 1×
“Upon liver injury, neutrophils are rapidly recruited to the injured site to remove the apoptotic cells [61].”
BackgroundIredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 4×
“Almost half of the activated HSCs died after ceasing CCl 4 -dependent liver injury [198–200].”
BackgroundInfluentialLiver sinusoidal endothelial cells: Physiology and role in liver diseases
Poisson, J., Lemoinne, S., Boulanger, C., Durand, F., Moreau, R., Valla, D., & Rautou, P.-E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.009 · Cited by 1,047 · cited 2×
“In the healthy liver, differentiated LSECs are gatekeepers of fibrogenesis by maintaining HSCs in their quiescent state [111,112].”
BackgroundRamachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001 · cited 4×
“The activity of these enzymes is further orchestrated by inhibitory molecules referred to as tissue inhibitors of metalloproteinases (TIMPs) [74,187,198].”
BackgroundInfluentialBile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
Islam, K. B. M. S., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., Ogura, Y., Hayashi, T., & Yokota, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.046 · Cited by 918 · cited 1×
“If low levels of primary bile acids reach the small intestine, proinflammatory bacteria proliferate and the production of toxic bile acids increases, which promotes liver damage and inflammation [102].”
BackgroundModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866 · cited 2×
“KC-and HSC-derived CCL2 contribute to the increased differentiation of immature monocyte-derived LYC6C hi macrophages in the liver [89].”
BackgroundGut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843 · cited 1×
“Also, the intestinal microbiome influences hepatic bile acid metabolism and the translocation of gut-derived signals due to leaky gut; these parameters may be found to be predictive of clinical outcomes in patients with chronic liver disease [92–94].”
BackgroundTGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805 · cited 1×
“Its underlying basic mechanisms are usually investigated in experimental mouse models [3,183–185].”
BackgroundHepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803 · cited 10×
“Inflammation, the hallmark of chronic liver disease, drives progressive ECM deposition over time, which, in the long term, can progress to liver cirrhosis, end-stage liver failure, and liver cancer [4,5].”
BackgroundInfluentialToll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737 · cited 2×
“As a result of the gut’s permeability defect, the intestinal microbiome and the liver interact through bacteria and bacterial metabolites, which affect liver metabolism and further drive hepatic inflammation [95].”
BackgroundMouries, J., Brescia, P., Silvestri, A., Spadoni, I., Sorribas, M., Wiest, R., Mileti, E., Galbiati, M., Invernizzi, P., Adorini, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.005 · Cited by 688
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671 · cited 1×
“Activated HSCs are eliminated by a bouquet of options that include not only apoptosis and cellular senescence but also reversion to the inactivated HSC phenotype [4,5,16].”
BackgroundHernández–Gea, V., Ghiassi–Nejad, Z., Rozenfeld, R., Gordon, R., Fiel, M. I., Yue, Z., Czaja, M. J., & Friedman, S. L. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.044 · Cited by 654 · cited 2×
“Endoplasmic reticulum (ER) stress signals promote gene expression in HSCs by inducing autophagy and HSC activation [118,157,158].”
BackgroundFarnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639 · cited 2×
“Conversely, hepatocellular FXR activation by different bile acids prevents the upregulation of inflammatory response genes and induces cell survival [103].”
BackgroundDivergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Ding, B.-S., Cao, Z., Lis, R., Nolan, D. J., Guo, P., Simons, M., Penfold, M. E., Shido, K., Rabbany, S. Y., & Rafii, S. (2014) · Nature · doi:10.1038/nature12681 · Cited by 626 · cited 9×
“This is due to the fact that DCs serve as key professional APCs that regulate and orchestrate innate and adaptive immune responses in infections, chronic inflammatory diseases, cancer, autoimmunity, and, conversely, the induction of immune tolerance [132,138].”
BackgroundInfluentialBaeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609 · cited 1×
“During the regression of liver fibrosis, macrophages differentiate into a LY6C low phenotype, stop the production of proinflammatory and fibrogenic factors, and secrete MMPs [90].”
BackgroundRemmerie, A., Martens, L., Thoné, T., Castoldi, A., Seurinck, R., Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.004 · Cited by 592
Lok, A. S. F., McMahon, B. J., Brown, R. S., Wong, J. B., Ahmed, A. T., Farah, W., Almasri, J., Alahdab, F., Benkhadra, K., Mouchli, M. A., et al. (2016) · Hepatology · doi:10.1002/hep.28280 · Cited by 552 · cited 1×
“Still, better therapeutic strategies are currently being developed [218–220].”
BackgroundFleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544 · cited 1×
“Bile acids, such as cholic and chenodeoxycholic acid (CDCA), are important signaling molecules and are synthesized from cholesterol in hepatocytes surrounding the hepatic central vein [100].”
BackgroundGenetic programs of epithelial cell plasticity directed by transforming growth factor-β
Zavadil, J., Bitzer, M., Liang, D., Yang, Y.-C., Massimi, A., Kneitz, S., Piek, E., & Böttinger, E. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111614398 · Cited by 536 · cited 5×
“While these cells are found in virtually every tissue, their molecular signatures differ between organs [45,46].”
BackgroundInfluentialOrigin of myofibroblasts in the fibrotic liver in mice
Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T. J., Park, T. J., Liu, X., Xu, J., Wang, P., Paik, Y.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400062111 · Cited by 535 · cited 9×
“In biliary fibrosis models, 70% of the myofibroblast population are derived from activated fibroblasts at the onset of cholestatic injury, while the majority of myofibroblasts in later stages of the disease was found to originate from HSCs [43].”
BackgroundResultInfluentialInterdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription
Engel, M. E., McDonnell, M. A., Law, B. K., & Moses, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37413 · Cited by 531
Apoptosis: The nexus of liver injury and fibrosis
Canbay, A., Friedman, S., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20051 · Cited by 527 · cited 1×
“Damaged and apoptotic hepatocytes induce HSC activation by degrading the regular ECM composition in the space of Disse, releasing reactive oxygen species and proinflammatory cytokines and recruiting immune cells, which collectively perpetuates HSC activation [54–57].”
BackgroundSelf-citationLiver sinusoidal endothelial cells — gatekeepers of hepatic immunity
Shetty, S., Lalor, P. F., & Adams, D. H. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0020-y · Cited by 523 · cited 2×
“LSECs actively participate in the clearance of antigens reaching the liver sinusoids and contribute to the perpetuation of the tolerogenic state [116,117].”
BackgroundUnderstanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada, P., González-Rodríguez, Á., García-Monzón, C., & Valverde, Á. M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03003-w · Cited by 518 · cited 1×
“…growth factors, and distinct signals, including cell–cell contact with macrophages, cytokines derived from activated immune cells, and pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs), mediate the activation of HSCs during liver injury [2–5, 14,15].”
BackgroundDeactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Troeger, J. S., Mederacke, I., Gwak, G., Dapito, D. H., Mu, X., Hsu, C. C., Pradere, J., Friedman, R. A., & Schwabe, R. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.036 · Cited by 515 · cited 7×
“Mitophagy is orchestrated by distinct dynamics, and the PINK1/Parkin pathway is thought to be the most relevant regulatory path [4,5,186,194].”
BackgroundInfluentialKisseleva, T., & Brenner, D. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-190 · Cited by 503 · cited 4×
“Studies on the origin of hepatic myofibroblasts have documented their heterogenous derivation, which inter alia includes HSCs, portal fibroblasts, and bone marrow-derived cells such as fibrocytes and mesenchymal stem cells [40–42].”
BackgroundInfluentialContribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Chopyk, D. M., & Grakoui, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.077 · Cited by 490 · cited 1×
“Also, the intestinal microbiome influences hepatic bile acid metabolism and the translocation of gut-derived signals due to leaky gut; these parameters may be found to be predictive of clinical outcomes in patients with chronic liver disease [92–94].”
BackgroundThe Bone Marrow Functionally Contributes to Liver Fibrosis
Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., Bou–Gharios, G., Jeffery, R., Iredale, J. P., & Forbes, S. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.036 · Cited by 483
Liver sinusoidal endothelial cells in hepatic fibrosis
DeLeve, L. D. (2015) · Hepatology · doi:10.1002/hep.27376 · Cited by 482 · cited 1×
“They play an important role in the secretion of vasoactive molecules, such as nitric oxide (NO) [113].”
BackgroundPinzani, M., Gesualdo, L., Sabbah, G. M., & Abboud, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114363 · Cited by 478 · cited 1×
“Autocrine PDGF-BB stimulation is most potent to induce HSC proliferation [32,33].”
BackgroundEpigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476 · cited 5×
“They extensively modulate gene expression at the transcriptional, post-transcriptional, and epigenetic levels by interacting with proteins, DNA, or mRNAs [165].”
BackgroundInfluentialSeidman, J. S., Troutman, T. D., Sakai, M., Gola, A., Spann, N. J., Bennett, H., Bruni, C. M., Ouyang, Z., Li, R. Z., Sun, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.001 · Cited by 443
Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J.-I., Shibuya, H., Matsumoto, K., & Nishida, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27161 · Cited by 442
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future
Friedman, S. L., & Pinzani, M. (2022) · Hepatology · doi:10.1002/hep.32285 · Cited by 430 · cited 10×
“Both HSCs and KCs have been considered to be sources of matrix metalloproteinases (MMPs) [53,58].”
BackgroundInfluentialMechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 429 · cited 3×
“These observations demonstrate that the regression of liver fibrosis, at least in part, is a dynamic process due to HSC transformation in the healing liver [4,197–200].”
BackgroundThe Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
Trivedi, P., Wang, S., & Friedman, S. L. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.026 · Cited by 427 · cited 1×
“These findings have demonstrated that senescence of activated HSCs is a relevant mechanism in the eradication of HSCs in the context of liver fibrosis resolution [190,201].”
BackgroundApoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069036.63405.5c · Cited by 417
Self-citationPathogenesis of Nonalcoholic Steatohepatitis: An Overview
Parthasarathy, G., Revelo, X., & Malhi, H. (2020) · Hepatology Communications · doi:10.1002/hep4.1479 · Cited by 414 · cited 1×
“In addition, dysfunctional gut permeability enables PAMPs and DAMPs to enter the liver where they activate immune cells and engage with hepatic Toll-like receptors (TLRs) to induce proinflammatory and fibrotic pathways [97,98].”
BackgroundXie, G., Wang, X., Wang, L., Wang, L., Atkinson, R. D., Kanel, G. C., Gaarde, W. A., & DeLeve, L. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.017 · Cited by 410 · cited 2×
“Preclinical models of liver fibrosis have revealed the increased production of vaso con-strictors by LSECs [121].”
BackgroundRole of liver sinusoidal endothelial cells in liver diseases
Gracia-Sancho, J., Caparrós, E., Fernández-Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 410
DeLeve, L. D., Wang, X., & Guo, Y. (2008) · Hepatology · doi:10.1002/hep.22351 · Cited by 408 · cited 3×
“A study in cirrhotic rats revealed that the administration of a sGC activator that induces the VEGF-eNOS-sGC-cGMP pathway restored LSEC fenestration, resulting in HSC quiescence and cirrhosis regression [120].”
BackgroundFriedman, S. L., & Arthur, M. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114362 · Cited by 401 · cited 1×
“Autocrine PDGF-BB stimulation is most potent to induce HSC proliferation [32,33].”
BackgroundTran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gélineau, A., Marcelin, G., Magréau-Davy, E., Ouhachi, M., Lesnik, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.003 · Cited by 400
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Mann, J., Chu, D. C. K., Maxwell, A., Oakley, F., Zhu, N., Tsukamoto, H., & Mann, D. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.002 · Cited by 397 · cited 3×
“MeCP2 silences PPAR γ via different mechanisms [178].”
BackgroundInfluentialRelationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease
Murphy, S. K., Yang, H., Moylan, C. A., Pang, H., Dellinger, A., Abdelmalek, M. F., Garrett, M. E., Ashley–Koch, A., Suzuki, A., Tillmann, H. L., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.047 · Cited by 391 · cited 1×
“A genome-wide study of DNA methylation patterns in CCl 4 mouse liver tissues revealed the hypomethylation of fibrosis-related genes before the onset of liver fibrosis [170].”
BackgroundRockey, D. C., & Weisiger, R. A. (1996) · Hepatology · doi:10.1002/hep.510240137 · Cited by 385 · cited 1×
“Downregulation of eNOS and bioavailability have been shown in cirrhotic rat liver [123].”
BackgroundA role for autophagy during hepatic stellate cell activation
Thoen, L. F. R., Guimarães, E. L. M., Dollé, L., Mannaerts, I., Najimi, M., Sokal, E., & van Grunsven, L. A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.010 · Cited by 385 · cited 4×
“Endoplasmic reticulum (ER) stress signals promote gene expression in HSCs by inducing autophagy and HSC activation [118,157,158].”
BackgroundInfluentialDaemen, S., Gainullina, A., Kalugotla, G., He, L., Chan, M. M., Beals, J. W., Liss, K. H., Klein, S., Feldstein, A. E., Finck, B. N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108626 · Cited by 378
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases
Gao, B., Radaeva, S., & Park, O. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309135 · Cited by 377 · cited 2×
“It has been estimated that ~50% of activated HSCs are eliminated by apoptosis during the regression liver fibrosis [196].”
BackgroundAzzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369 · cited 1×
“In metabolic liver disease, free fatty acids flowing from adipose tissue to the liver may promote lipotoxicity and inflammation, particularly in patients with insulin resistance [104].”
BackgroundInnate lymphoid cells: major players in inflammatory diseases
Ebbo, M., Crinier, A., Vély, F., & Vivier, E. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.86 · Cited by 363 · cited 2×
“Clinical and experimental studies have demonstrated that cNK cells are critically involved in the immune pathogenesis of chronic liver disease (CLD), and they display antifibrotic activity through the induction of apoptosis and/or killing of activated HSCs [132,133,135].”
BackgroundShah, V, Haddad, F. G., Garcia-Cardena, G., Frangos, J. A., Mennone, A., Groszmann, R. J., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119842 · Cited by 350 · cited 2×
“In addition, they act as regional antigen-presenting cells (APCs) that govern, in addition to hepatic DCs and KCs, intrahepatic immune responses by secreting cytokines and by activating or inhibiting immune cell signaling pathways [114,115].”
BackgroundImajo, K., Fujita, K., Yoneda, M., Nozaki, Y., Ogawa, Y., Shinohara, Y., Kato, S., Mawatari, H., Shibata, W., Kitani, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.012 · Cited by 341 · cited 1×
“Furthermore, experimental trials have revealed that adipose tissue-derived leptin activates KCs and increases their responsiveness to endotoxin, which results in inflammation [105,106].”
BackgroundDu, K., Hyun, J., Premont, R. T., Choi, S. S., Michelotti, G. A., Swiderska-Syn, M., Dalton, G. D., Thelen, E., Rizi, B. S., Jung, Y., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.12.022 · Cited by 339 · cited 3×
“The combination of low extracellular pH with an increased lactic acid level promotes myofibroblast transformation through the activation of TGF-β 1 [1,144–146].”
BackgroundHepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Taura, K., Miura, K., Iwaisako, K., Österreicher, C. H., Kodama, Y., Penz-Österreicher, M., & Brenner, D. A. (2010) · Hepatology · doi:10.1002/hep.23368 · Cited by 336 · cited 2×
“Differentiation of quiescent HSCs into activated HSCs is a two-step process: The initiation phase encompasses the priming of HSCs, which sensitizes them to fibrogenic and proliferative cytokines [41,47,48,53].”
BackgroundAn integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321 · cited 1×
“…liver disease, the gut–liver axis, which refers to the anatomical and physiological connection between the liver and gut, is influenced by dietary fat and protein, bacterial metabolites, PAMPs, and intestinal and adipose tissue hormones; this may promote the progression of liver disease [91].”
BackgroundHazra, S., Xiong, S., Wang, J., Rippe, R. A., Krishna, V., Chatterjee, K., & Tsukamoto, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310284200 · Cited by 320 · cited 1×
“The MeCP2-mediated transdifferentiation of HSCs is, in part, regulated by the two distinct histone methyltransferases EZH2 and ASH1 [179].”
BackgroundIssa, R., Williams, E., Trim, N., Kendall, T., Arthur, M. J. P., Reichen, J., Benyon, R. C., & Iredale, J. P. (2001) · Gut · doi:10.1136/gut.48.4.548 · Cited by 319 · cited 8×
“Mitophagy is orchestrated by distinct dynamics, and the PINK1/Parkin pathway is thought to be the most relevant regulatory path [4,5,186,194].”
BackgroundInfluentialAn, P., Wei, L.-L., Zhao, S., Sverdlov, D. Y., Vaid, K. A., Miyamoto, M., Kuramitsu, K., Lai, M., & Popov, Y. V. (2020) · Nature Communications · doi:10.1038/s41467-020-16092-0 · Cited by 319 · cited 8×
“Mitochondrially originated danger signals from damaged hepatocytes directly activate HSCs and drive the progression of liver fibrosis [68].”
BackgroundInfluentialLiver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307 · cited 7×
“A CD11b hi /F4/80 inf LY6C low macrophage subpopulation was identified during the resolution of liver fibrosis; these special cells do not produce fibrogenic and/or inflammatory factors, but they continue to secrete MMPs, including MMP9 and MMP12 [59,74,89], and they upregulate CX3CR1.”
BackgroundInfluentialCasini, A., Ceni, E., Salzano, R., Biondi, P., Parola, M., Galli, A., Foschi, M., Caligiuri, A., Pinzani, M., & Surrenti, C. (1997) · Hepatology · doi:10.1002/hep.510250218 · Cited by 302
Phagocytosis of Apoptotic Cells in Resolution of Inflammation
Kourtzelis, I., Hajishengallis, G., & Chavakis, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00553 · Cited by 300
Jeong, W.-I., Park, O., Radaeva, S., & Gao, B. (2006) · Hepatology · doi:10.1002/hep.21419 · Cited by 275 · cited 1×
“Comprehensive information on the molecular and cellular mechanisms underlying fibrosis resolution is required to develop potential novel drugs [58,204,205].”
BackgroundPortal fibroblasts: Underappreciated mediators of biliary fibrosis†
Dranoff, J. A., & Wells, R. G. (2010) · Hepatology · doi:10.1002/hep.23405 · Cited by 273 · cited 4×
“Portal fibroblasts were initially defined as periductal fibroblasts and periportal mesenchymal cells and were implicated in the pathogenesis of cholestatic liver injury in experimental models and patients alike [45].”
BackgroundInfluentialCCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Ehling, J., Bartneck, M., Wei, X., Gremse, F., Fech, V., Möckel, D., Baeck, C., Hittatiya, K., Eulberg, D., Luedde, T., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306294 · Cited by 273 · cited 1×
“There is a close relationship between liver fibrosis and angiogenesis in that fibrosis fosters angiogenesis and, in turn, liver angiogenesis exacerbates liver fibrosis [127,128].”
BackgroundCellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., & Marra, F. (2021) · Cells · doi:10.3390/cells10102759 · Cited by 270 · cited 7×
“These findings proved that TRAIL may be a potential proapoptotic agent to deplete activated HSCs in liver fibrosis and cirrhosis [195].”
BackgroundInfluentialThabut, D., & Shah, V. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.004 · Cited by 266 · cited 1×
“In addition to LSECs, endothelial progenitor cells (EPCs), i.e., bone marrow-derived endothelial cells, also contribute to intrahepatic angiogenesis [129,130].”
BackgroundP38 Mapk Mediates Fibrogenic Signal Through Smad3 Phosphorylation in Rat Myofibroblasts
Furukawa, F., Matsuzaki, K., Mori, S., Tahashi, Y., Yoshida, K., Sugano, Y., Yamagata, H., Matsushita, M., Seki, T., Inagaki, Y., et al. (2003) · Hepatology · doi:10.1002/hep.1840380414 · Cited by 265
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
Cheng, J. H., She, H., Han, Y.-P., Wang, J., Xiong, S., Asahina, K., & Tsukamoto, H. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2007 · Cited by 258 · cited 7×
“Epigenetic factors such as the methyl-CpG-binding protein 2 (MeCP2) mediate silencing of the PPAR γ -encoding gene or the transcriptional activation of profibrogenic genes via specific histone modification [184].”
BackgroundInfluentialSingle-cell technologies in hepatology: new insights into liver biology and disease pathogenesis
Ramachandran, P., Matchett, K. P., Dobie, R., Wilson-Kanamori, J. R., & Henderson, N. C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0304-x · Cited by 253 · cited 1×
“Their synthesis is regulated by the farnesoid X receptor (FXR) mainly via downstream targets [101].”
BackgroundTGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis
Bonniaud, P., Margetts, P. J., Ask, K., Flanders, K., Gauldie, J., & Kolb, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5390 · Cited by 252
Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice
Czochra, P., Klopcic, B., Meyer, E., Herkel, J., Garcia-Lazaro, J. F., Thieringer, F., Schirmacher, P., Biesterfeld, S., Galle, P. R., Lohse, A. W., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.04.010 · Cited by 244 · cited 1×
“Interestingly, experimental PDGFR-β deletion resulted in the regression of liver fibrosis, whereas the activation of this receptor enhanced fibrogenesis [37,38].”
BackgroundEndoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy
Hernández-Gea, V., Hilscher, M., Rozenfeld, R., Lim, M. P., Nieto, N., Werner, S., Devi, L. A., & Friedman, S. L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.016 · Cited by 236 · cited 1×
“An experimental trial in mice has indicated that liver fibrosis is substantially diminished in JNK1-deficient mice compared to wild-type mice and in those with hepatocyte-specific JNK1 deficiency in response to CCl 4 or BDL [159].”
BackgroundVerbeke, L., Mannaerts, I., Schierwagen, R., Govaere, O., Klein, S., Vander Elst, I., Windmolders, P., Farre, R., Wenes, M., Mazzone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33453 · Cited by 236 · cited 1×
“Farsenoid X receptor (FXR) is a key regulator of hepatic bile homeostasis, lipoprotein, and glucose metabolism, which has inhibitory effects on HSC activation [210,211].”
BackgroundTherapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
van der Heide, D., Weiskirchen, R., & Bansal, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02852 · Cited by 234 · cited 2×
“In the setting of liver injury in mice, hepatic CXCR6 + NKT cells promote the release of inflammatory cytokines such as IFN γ and IL-4 that drive liver fibrosis [195,203].”
BackgroundFarnesoid X receptor (FXR): Structures and ligands
Jiang, L., Zhang, H., Xiao, D., Wei, H., & Chen, Y. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.029 · Cited by 231 · cited 2×
“Obeticholic acid, the first molecule to target FXR to be approved by the FDA in 2016 as a second-line treatment for primary biliary cholangitis, has been shown to improve fibrosis in NASH patients [211].”
BackgroundMinutti, C. M., Modak, R. V., Macdonald, F., Li, F., Smyth, D. J., Dorward, D. A., Blair, N., Husovsky, C., Muir, A., Giampazolias, E., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.008 · Cited by 228 · cited 2×
“They also reported that ~38% of genes differently expressed by quiescent HSCs and activated HSCs are involved in protein metabolism [75].”
BackgroundScholten, D., Österreicher, C. H., Scholten, A., Iwaisako, K., Gu, G., Brenner, D. A., & Kisseleva, T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.005 · Cited by 227 · cited 1×
“Differentiation of quiescent HSCs into activated HSCs is a two-step process: The initiation phase encompasses the priming of HSCs, which sensitizes them to fibrogenic and proliferative cytokines [41,47,48,53].”
BackgroundSchnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224 · cited 2×
“Following the halting of CCl 4 injury, p53 suppression causes the persistence of activated HSCs and stops liver fibrosis resolution [202].”
BackgroundPovero, D., Panera, N., Eguchi, A., Johnson, C. D., Papouchado, B. G., de Araujo Horcel, L., Pinatel, E. M., Alisi, A., Nobili, V., & Feldstein, A. E. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.07.007 · Cited by 221 · cited 3×
“These microRNAs, when released from the extracellular vesicles upon their uptake by HSCs, inhibit the expression of peroxisome proliferator-activated receptor (PPAR) γ , which shifts quiescent HSCs to the activated HSC phenotype [108].”
BackgroundKrenkel, O., Hundertmark, J., Abdallah, A. T., Kohlhepp, M., Puengel, T., Roth, T., Branco, D. P. P., Mossanen, J. C., Luedde, T., Trautwein, C., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318382 · Cited by 220
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
Kluwe, J., Pradere, J., Gwak, G., Mencin, A., De Minicis, S., Österreicher, C. H., Colmenero, J., Bataller, R., & Schwabe, R. F. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.015 · Cited by 217 · cited 2×
“There are three fundamental mechanisms of epigenetic regulation, i.e., noncoding RNA (ncRNA) expression, DNA methylation, and histone modification [160].”
BackgroundChu, A. S., Diaz, R., Hui, J.-J., Yanger, K., Zong, Y., Alpini, G., Stanger, B. Z., & Wells, R. G. (2011) · Hepatology · doi:10.1002/hep.24206 · Cited by 208 · cited 1×
“DNMT-mediated hypermethylation of phosphatase and tensin homolog (PTEN) initiates the activation of HSCs [39,49].”
BackgroundSingh, S., Facciorusso, A., Loomba, R., & Falck-Ytter, Y. T. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.038 · Cited by 208 · cited 1×
“The regression of liver fibrosis in patients with HCV-related liver cirrhosis with a sustained virological response upon DAA treatment could be demonstrated by related pathological parameters and/or by measuring liver stiffness with transient elastography (FibroScan) [221,222].”
BackgroundCholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Wang, X., Cai, B., Yang, X., Sonubi, O. O., Zheng, Z., Ramakrishnan, R., Shi, H., Valenti, L., Pajvani, U. B., Sandhu, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.010 · Cited by 204 · cited 9×
“KLF2 is a nuclear transcription factor sensitive to shear stress, enabling endothelial vaso-protection [110,118].”
BackgroundInfluentialSonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells
Yang, L., Wang, Y., Mao, H., Fleig, S., Omenetti, A., Brown, K. D., Sicklick, J. K., Li, Y.-X., & Diehl, A. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.032 · Cited by 200 · cited 1×
“In HSCs, PDGFR-β activation induces their proliferation and migration, drives cell survival, and promotes the expression of hedgehog pathway ligands, such as sonic hedgehog, which triggers HSC activation [35,36].”
BackgroundWiesner, R. J., Rüegg, J. C., & Morano, I. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90517-o · Cited by 197 · cited 1×
“Mitochondria-derived danger signals (mito-DAMPs) are abundant in the liver, as hepatocytes comprise a high number of mitochondria due to their high metabolic activity [67] (see also below).”
BackgroundChanging Concepts of Cirrhotic Coagulopathy
Tripodi, A., Primignani, M., Mannucci, P. M., & Caldwell, S. H. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.498 · Cited by 193 · cited 1×
“There is a close relationship between liver fibrosis and angiogenesis in that fibrosis fosters angiogenesis and, in turn, liver angiogenesis exacerbates liver fibrosis [127,128].”
BackgroundKocabayoglu, P., Lade, A., Lee, Y. A., Dragomir, A.-C., Sun, X., Fiel, M. I., Thung, S., Aloman, C., Soriano, P., Hoshida, Y., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.036 · Cited by 184 · cited 2×
“Interestingly, experimental PDGFR-β deletion resulted in the regression of liver fibrosis, whereas the activation of this receptor enhanced fibrogenesis [37,38].”
BackgroundLiver nbsp fibrosis signals leading to the amplification of the fibrogenic hepatic stellate cell
Rippe, R. A. (2003) · Frontiers in Bioscience · doi:10.2741/887 · Cited by 183 · cited 2×
“As such, the autocrine stimulation of HSCs by TGF-β and PDGF-AA initiates HSC activation and perpetuates liver fibrosis [20,31,34].”
BackgroundBöttcher, K., Rombouts, K., Saffioti, F., Roccarina, D., Rosselli, M., Hall, A., Luong, T., Tsochatzis, E. A., Thorburn, D., & Pinzani, M. (2018) · Hepatology · doi:10.1002/hep.29782 · Cited by 183 · cited 4×
“Increasing evidence suggests that adaptive immune cells, including Th1, Th2, and Th17 cells, also play important roles in liver fibrogenesis [141].”
BackgroundInfluentialHepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives
Zhang, M., Serna-Salas, S., Damba, T., Borghesan, M., Demaria, M., & Moshage, H. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111572 · Cited by 179 · cited 5×
“Therefore, induction of senescence in HSCs is a promising potential antifibrotic strategy [191,192].”
BackgroundResultInfluentialMoles, A., Murphy, L., Wilson, C. L., Chakraborty, J. B., Fox, C., Park, E. J., Mann, J., Oakley, F., Howarth, R., Brain, J., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.005 · Cited by 169 · cited 1×
“In mice, the elimination of neutrophils or the deletion of neutrophil-derived soluble molecules (IL-8, IL-18, IL-17, CCL3, CCl 4 , and CCL2) attenuates the development of hepatic fibrosis [63,64].”
Backgroundde Gouville, A., Boullay, V., Krysa, G., Pilot, J., Brusq, J., Loriolle, F., Gauthier, J., Papworth, S. A., Laroze, A., Gellibert, F., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706172 · Cited by 166
Ge, J., Cui, H., Xie, N., Banerjee, S., Guo, S., Dubey, S., Barnes, S., & Liu, G. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0238oc · Cited by 166 · cited 1×
“Increased glycolysis and glutaminolysis, together with enhanced fatty acid oxidation, have been considered to be relevant drivers of fibroblast activation [150].”
BackgroundYoshida, K., Matsuzaki, K., Mori, S., Tahashi, Y., Yamagata, H., Furukawa, F., Seki, T., Nishizawa, M., Fujisawa, J., & Okazaki, K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62324-3 · Cited by 165
Gracia‐Sancho, J., Laviña, B., Rodríguez‐Vilarrupla, A., García‐Calderó, H., Fernández, M., Bosch, J., & García‐Pagán, J. (2008) · Hepatology · doi:10.1002/hep.22166 · Cited by 156 · cited 10×
“KLF2 is a nuclear transcription factor sensitive to shear stress, enabling endothelial vaso-protection [110,118].”
BackgroundInfluentialGracia-Sancho, J., Russo, L., García-Calderó, H., García-Pagán, J. C., García-Cardeña, G., & Bosch, J. (2011) · Gut · doi:10.1136/gut.2010.220913 · Cited by 156 · cited 2×
“LSECs may also play a role in the pathogenesis of portal hypertension through a dysregulation of their antithrombotic capacity [125,126].”
BackgroundFibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Rockey, D. C., & Friedman, S. L. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.065 · Cited by 156 · cited 1×
“The regression of liver fibrosis in patients with HCV-related liver cirrhosis with a sustained virological response upon DAA treatment could be demonstrated by related pathological parameters and/or by measuring liver stiffness with transient elastography (FibroScan) [221,222].”
BackgroundHistopathological evaluation of liver fibrosis and cirrhosis regression
Lo, R. C., & Kim, H. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0078 · Cited by 151 · cited 3×
“While no drug has as yet been approved for the treatment of liver fibrosis, some novel treatment approaches have been shown to be effective in patients with chronic viral hepatitis that were successfully treated with antivirals [58,199].”
BackgroundThe Roles of Immune Cells in the Pathogenesis of Fibrosis
Huang, E., Peng, N., Xiao, F., Hu, D., Wang, X., & Lu, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155203 · Cited by 143 · cited 8×
“Clinical and experimental studies have demonstrated that cNK cells are critically involved in the immune pathogenesis of chronic liver disease (CLD), and they display antifibrotic activity through the induction of apoptosis and/or killing of activated HSCs [132,133,135].”
BackgroundInfluentialde Jong, O. G., van Balkom, B. W. M., Gremmels, H., & Verhaar, M. C. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12730 · Cited by 142 · cited 1×
“…stem cell transplantation, including MSCs, endothelial progenitors, and hematopoietic stem cells, is an effective means to repair fibrotic livers in experimental models; they stimulate hepatic proliferation, inhibit activated HSCs, increase MMP activity, and induce neovascularization [214,215].”
BackgroundEpigenetics and Liver Fibrosis
Moran-Salvador, E., & Mann, J. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.04.007 · Cited by 136 · cited 1×
“The expression of MeCP2, a methyl-binding protein, is promoted during the transition of HSCs to myofibroblasts [176].”
BackgroundChen, M., Liu, J., Yang, W., & Ling, W. (2017) · Autophagy · doi:10.1080/15548627.2017.1356550 · Cited by 135 · cited 3×
“In addition, macrophage-derived PGE 2 can drive HSC activation and fibrosis through promoting autophagy [154].”
BackgroundInfluentialNishio, T., Hu, R., Koyama, Y., Liang, S., Rosenthal, S. B., Yamamoto, G., Karin, D., Baglieri, J., Ma, H.-Y., Xu, J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.012 · Cited by 135 · cited 3×
“However, both activated HSCs and portal fibroblasts promote cholestatic liver fibrosis caused by periportal injury [43,44].”
BackgroundResultp38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts
Furukawa, F. (2003) · Hepatology · doi:10.1053/jhep.2003.50384 · Cited by 135
Perugorria, M. J., Wilson, C. L., Zeybel, M., Walsh, M., Amin, S., Robinson, S., White, S. A., Burt, A. D., Oakley, F., Tsukamoto, H., et al. (2012) · Hepatology · doi:10.1002/hep.25754 · Cited by 134 · cited 1×
“Overexpression of EZH2 promotes the expression of fibronectin, α -SMA, and collagen 1 α 1 in HSCs [180].”
BackgroundBian, E., Huang, C. Z., Ma, T., Tao, H., Zhang, H., Chang, C. K., Lv, X., & Li, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.06.022 · Cited by 134 · cited 1×
“DNA methylation is orchestrated upon the attachment of methyl-binding proteins, which subsequently accumulate the transcriptional repressor complex [175].”
BackgroundChatterjee, S., Ganini, D., Tokar, E. J., Kumar, A., Das, S., Corbett, J., Kadiiska, M. B., Waalkes, M. P., Diehl, A. M., & Mason, R. P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.035 · Cited by 134 · cited 1×
“Furthermore, experimental trials have revealed that adipose tissue-derived leptin activates KCs and increases their responsiveness to endotoxin, which results in inflammation [105,106].”
BackgroundPage, A., Paoli, P., Moran Salvador, E., White, S., French, J., & Mann, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.024 · Cited by 134 · cited 1×
“Methylated CpG motifs within the promoter of PPAR γ accumulate methyl-CpG-binding protein 2 that subsequently promotes H3K9 methylation and accumulates transcriptional repressor chromobox protein homolog 5, which inhibits PPAR γ production and drives HSC activation [169].”
BackgroundYoshida, K., & Matsuzaki, K. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00053 · Cited by 131 · cited 2×
“As such, the autocrine stimulation of HSCs by TGF-β and PDGF-AA initiates HSC activation and perpetuates liver fibrosis [20,31,34].”
BackgroundPathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Khanam, A., Saleeb, P. G., & Kottilil, S. (2021) · Cells · doi:10.3390/cells10051097 · Cited by 131
Gracia-Sancho, J., Laviña, B., Rodríguez-Vilarrupla, A., García-Calderó, H., Bosch, J., & García-Pagán, J. C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.014 · Cited by 125 · cited 1×
“Activation of the cyclooxygenase 1 (COX1)-TXA2 pathway and endothelin 1 in rat chronic injury participate in sinusoidal contraction and exacerbate microvascular dysfunction [121,122].”
BackgroundHepatocytes: A key role in liver inflammation
Gong, J., Tu, W., Liu, J., & Tian, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1083780 · Cited by 125 · cited 4×
“Nucleotide-binding oligomerization domain-like receptors (NLRP3) are a fundamental component of the inflammasome and the downstream targets of DAMPs [59,107].”
BackgroundInfluentialKendall, T. J., Hennedige, S., Aucott, R. L., Hartland, S. N., Vernon, M. A., Benyon, R. C., & Iredale, J. P. (2009) · Hepatology · doi:10.1002/hep.22701 · Cited by 121 · cited 10×
“The ECM production in activated HSCs that become senescent is reduced so that fibrogenesis decreases [187,191].”
BackgroundInfluentialPeng, Z., Ikenaga, N., Liu, S. B., Sverdlov, D. Y., Vaid, K. A., Dixit, R., Weinreb, P. H., Violette, S., Sheppard, D., Schuppan, D., et al. (2016) · Hepatology · doi:10.1002/hep.28274 · Cited by 118 · cited 4×
“Activated HSCs have been shown to increase the rate of aerobic glycolysis and related enzymes while decreasing the enzymes involved in gluconeogenesis [151].”
BackgroundInfluentialHepatic Stellate Cell Regulation of Liver Regeneration and Repair
Kitto, L. J., & Henderson, N. C. (2021) · Hepatology Communications · doi:10.1002/hep4.1628 · Cited by 117 · cited 7×
“Both HSCs and KCs have been considered to be sources of matrix metalloproteinases (MMPs) [53,58].”
BackgroundInfluentialMesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Koyama, Y., Wang, P., Liang, S., Iwaisako, K., Liu, X., Xu, J., Zhang, M., Sun, M., Cong, M., Karin, D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88845 · Cited by 111 · cited 3×
“In activated portal fibroblasts, the crosstalk between mesothelin (MSLN), musin 16 (MUC16), and THY1 surface receptors orchestrates TGF-β 1-TGF-β R1-SMAD2/3-promoted fibrogenic responses and proliferation via MSLN-AKT-FGFR1-dependent signaling [60].”
BackgroundCalvaruso, V., & Craxì, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.006 · Cited by 110
Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
Sharma, S. K., Guillou, D. L., & Chen, J. Y. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00832-w · Cited by 110 · cited 3×
“…with LSECs cocultured with HSCs revealed the role of capillarized LSECs on HSC activation; specifically, LSECs from normal rat liver prevented HSC activation and induced their reversion to a quiescent phenotype, whereas capillarized LSECs were not capable of inducing this phenotype [118,119].”
BackgroundPiaz, V. D., & Giovannoni, M. P. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)00179-3 · Cited by 106 · cited 1×
“The Wnt/ β -catenin signaling pathway plays a critical role in HSC activation; therefore, this pathway could also be a potential target for resolving fibrosis [209].”
BackgroundKupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution
Feng, M., Ding, J., Wang, M., Zhang, J., Zhu, X., & Guan, W. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25589 · Cited by 106 · cited 1×
“The second messenger cAMP drives fibrosis regression and could be a potential target to slow down fibrosis [205,208].”
BackgroundWen, Y., Hou, Y., Yi, X., Sun, S., Guo, J., He, X., Li, T., Cai, J., & Wang, Z. (2020) · Theranostics · doi:10.7150/thno.48101 · Cited by 105 · cited 3×
“The existence of various transcription factors was suggested to orchestrate this process, but suitable models on the reprogramming of the myofibroblast epigenome are still missing [167].”
BackgroundLiu, C., Chen, X., Yang, L., Kisseleva, T., Brenner, D. A., & Seki, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.543769 · Cited by 103 · cited 1×
“ILCs, particularly ILC1s and ILC3s, are involved in liver fibrogenesis [82,83].”
BackgroundIncreased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
Du, K., Chitneni, S. K., Suzuki, A., Wang, Y., Henao, R., Hyun, J., Premont, R. T., Naggie, S., Moylan, C. A., Bashir, M. R., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.12.006 · Cited by 103 · cited 1×
“The metabolism of lipid droplets during HSC activation generates fatty acids for β -oxi dation [43,147–149].”
BackgroundMederacke, I., Filliol, A., Affo, S., Nair, A., Hernandez, C., Sun, Q., Hamberger, F., Brundu, F., Chen, Y., Ravichandra, A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abe5795 · Cited by 103 · cited 2×
“In mice, an experimental P2Y 14 deficiency led to reduced fibrosis [65].”
BackgroundJin, Z., Sun, R., Wei, H., Gao, X., Chen, Y., & Tian, Z. (2011) · Hepatology · doi:10.1002/hep.23983 · Cited by 100 · cited 2×
“MAIT cells can promote HSC proliferation and the production of collagen and proinflammatory cytokines in vitro [140].”
BackgroundFrenette, C. T., Morelli, G., Shiffman, M. L., Frederick, R. T., Rubin, R. A., Fallon, M. B., Cheng, J. T., Cave, M. C., Khaderi, S. A., Massoud, O. I., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.06.012 · Cited by 100 · cited 1×
“Apoptosis inhibitors such as the pan-caspase apoptosis inhibitor emricasan have been investigated to determine their antifibrotic roles [212].”
BackgroundThe NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis
Knorr, J., Wree, A., Tacke, F., & Feldstein, A. E. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1708540 · Cited by 99 · cited 1×
“The formation of an inflammasome is a critical process that triggers the inflammatory response via IL-1β and IL-18, which eventually induces inflammatory cell death [69].”
BackgroundA strategy of vascular‐targeted therapy for liver fibrosis
Lin, Y., Dong, M., Liu, Z., Xu, M., Huang, Z., Liu, H., Gao, Y., & Zhou, W. (2022) · Hepatology · doi:10.1002/hep.32299 · Cited by 99 · cited 1×
“Recently, Lin et al. suggested a therapeutic strategy by targeting leukocyte-derived chemotaxis 2/tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domain (LECT2/Tie1) signaling with bevacizumab (anti-VEGF/VEGFR signaling) to reverse fibrosis [199,216,217].”
BackgroundAdipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity
Wang, H., Shen, L., Sun, X., Liu, F., Feng, W., Jiang, C., Chu, X., Ye, X., Jiang, C., Wang, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11270-1 · Cited by 98 · cited 1×
“Forkel et al. revealed a link between the severity of liver fibrosis and the proportion of intrahepatic ILC2s, which may express IL-13 and exhibit profibrotic activity [137].”
BackgroundCao, Y., Mai, W., Li, R., Deng, S., Li, L., Zhou, Y., Qin, Q., Zhang, Y., Zhou, X., Han, M., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04319-w · Cited by 97 · cited 3×
“In HSP47-depleted HSCs, immature type 1 procollagen accumulates [1,2,4,5,155].”
BackgroundExtra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yan, Y., Zeng, J., Xing, L., & Li, C. (2021) · Biomedicines · doi:10.3390/biomedicines9081014 · Cited by 96 · cited 3×
“Du et al. showed the expression of genes involved in protein metabolism during carbohydrate metabolism [145].”
BackgroundThe Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96 · cited 10×
“The MCP-1/CCR2 pathway is particularly activated in NASH patients [70].”
BackgroundInfluentialGalati, D., De Martino, M., Trotta, A., Rea, G., Bruzzese, D., Cicchitto, G., Stanziola, A. A., Napolitano, M., Sanduzzi, A., & Bocchino, M. (2014) · Cytokine · doi:10.1016/j.cyto.2013.12.003 · Cited by 95 · cited 10×
“Excessive ROS production activates TGF-β signaling and stimulates inflammatory cells that, as detailed further above, contribute to hepatic fibrogenesis [1,142].”
BackgroundInfluentialGlobal analysis of DNA methylation in early-stage liver fibrosis
Komatsu, Y., Waku, T., Iwasaki, N., Ono, W., Yamaguchi, C., & Yanagisawa, J. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-5 · Cited by 95 · cited 2×
“Although the transition of HSCs to myofibroblasts is associated with a general loss of DNA methylation, the presence of gene-specific DNA hypomethylation and hypermethylation has been documented in genome-wide DNA methylation studies [171,172].”
BackgroundIn Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
Lee, Y.-S., & Seki, E. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.05.010 · Cited by 94 · cited 10×
“HSCs are a nonparenchymal cell population that, in the healthy organ, accounts for around 5–8% of all liver cells [2,3].”
BackgroundInfluentialMAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming
Mabire, M., Hegde, P., Hammoutene, A., Wan, J., Caër, C., Sayegh, R. A., Cadoux, M., Allaire, M., Weiss, E., Thibault-Sogorb, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37453-5 · Cited by 93 · cited 5×
“Recent data from patients with chronic liver disease and murine models have revealed that liver fibrosis can regress even at later stages of cirrhosis [1,2,4,5,13].”
BackgroundInfluentialTornesello, M. L., Buonaguro, L., Izzo, F., & Buonaguro, F. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7837 · Cited by 92 · cited 3×
“Senescent HSCs are α -SMA-positive cells, but they neither proliferate nor produce collagen [2,5,10,11].”
BackgroundCombatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
Chen, L., Brenner, D. A., & Kisseleva, T. (2019) · Hepatology Communications · doi:10.1002/hep4.1290 · Cited by 91 · cited 2×
“Exosomes released into the serum might be useful antifibrotic tools [214].”
BackgroundMolecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
Bruneau, A., Hundertmark, J., Guillot, A., & Tacke, F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.725390 · Cited by 88
Prospective Isolation of Mesenchymal Stem Cells from Mouse Compact Bone
Short, B. J., Brouard, N., & Simmons, P. J. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-060-7_16 · Cited by 85 · cited 1×
“It has been reported that mesenchymal stem cells experimentally obtained from murine bone marrow proliferate in the liver and lead to an increase in tissue fibroblasts [52].”
BackgroundNovo, E., Povero, D., Busletta, C., Paternostro, C., di Bonzo, L. V., Cannito, S., Compagnone, A., Bandino, A., Marra, F., Colombatto, S., et al. (2012) · The Journal of Pathology · doi:10.1002/path.3005 · Cited by 84 · cited 2×
“Damaged and apoptotic hepatocytes induce HSC activation by degrading the regular ECM composition in the space of Disse, releasing reactive oxygen species and proinflammatory cytokines and recruiting immune cells, which collectively perpetuates HSC activation [54–57].”
BackgroundZeybel, M., Luli, S., Sabater, L., Hardy, T., Oakley, F., Leslie, J., Page, A., Moran Salvador, E., Sharkey, V., Tsukamoto, H., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.004 · Cited by 84 · cited 1×
“Methyl-CpG-binding protein and histone-lysine N -methyltransferase enhancer of zest homolog 2 (EZH2) regulate epigenetic signaling by repressing PPAR γ [182].”
BackgroundBian, E., Huang, C., Wang, H., Chen, X., Zhang, L., Lv, X., & Li, J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.10.038 · Cited by 80 · cited 1×
“Conversely, downregulation of the Smad7 and Pten genes is associated with DNA hypermethylation [174].”
BackgroundSUDO, K., YAMADA, Y., MORIWAKI, H., SAITO, K., & SEISHIMA, M. (2005) · Cytokine · doi:10.1016/j.cyto.2004.11.001 · Cited by 80
Forkel, M., Berglin, L., Kekäläinen, E., Carlsson, A., Svedin, E., Michaëlsson, J., Nagasawa, M., Erjefält, J. S., Mori, M., Flodström‐Tullberg, M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646890 · Cited by 80 · cited 2×
“Myeloid DCs (in the DC-specific literature differentiating between three principal DC subclasses, this one is dubbed “classical” or “conventional”) assume a critical role in the development of liver fibrosis [138].”
BackgroundHepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, L., Subramanian, P., & Hammerich, L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.010 · Cited by 80
TGF‑β1‑induced autophagy activates hepatic stellate cells via the ERK and JNK signaling pathways
Zhang, J., Jiang, N., Ping, J., & Xu, L. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4778 · Cited by 79 · cited 2×
“The lipopolysaccharide-induced upregulation of autophagy modulates the suppression of the TGF-β pseudo-receptor BAMBI [153].”
BackgroundOh, Y., Park, O., Swierczewska, M., Hamilton, J. P., Park, J., Kim, T. H., Lim, S., Eom, H., Jo, D. G., Lee, C., et al. (2016) · Hepatology · doi:10.1002/hep.28432 · Cited by 77 · cited 1×
“Once toxic liver damage is halted, activated HSCs evade apoptosis, reduce their expression of fibrogenic genes, and differentiate into quiescent HSC states [189–193].”
BackgroundHu, C., Zhao, L., Duan, J., & Li, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14115 · Cited by 77 · cited 1×
“Recently, Lin et al. suggested a therapeutic strategy by targeting leukocyte-derived chemotaxis 2/tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domain (LECT2/Tie1) signaling with bevacizumab (anti-VEGF/VEGFR signaling) to reverse fibrosis [199,216,217].”
BackgroundEl Taghdouini, A., Sørensen, A. L., Reiner, A. H., Coll, M., Verhulst, S., Mannaerts, I., Øie, C. I., Smedsrød, B., Najimi, M., Sokal, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4925 · Cited by 73 · cited 1×
“For instance, upregulation of profibrogenic genes such as Actg2, Loxl1, Loxl2, and Col4A1/2 is associated with a decrease in promoter methylation levels in activated HSCs [173].”
BackgroundPlatelets as Modulators of Liver Diseases
Luyendyk, J., & Lisman, T. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1604091 · Cited by 73 · cited 2×
“LSECs may also play a role in the pathogenesis of portal hypertension through a dysregulation of their antithrombotic capacity [125,126].”
BackgroundMartin-Mateos, R., De Assuncao, T. M., Arab, J. P., Jalan-Sakrikar, N., Yaqoob, U., Greuter, T., Verma, V. K., Mathison, A. J., Cao, S., Lomberk, G., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.005 · Cited by 73 · cited 1×
“Studies in in vitro and in vivo models of CCl 4 and BDL-induced liver fibrosis have demonstrated that EZH2 inhibitors such as 3-deazaneplanocin A (DZNep) and GSK-503 have antifibrotic properties [181].”
BackgroundMetabolic Reprogramming of Liver Fibrosis
Delgado, M. E., Cárdenas, B. I., Farran, N., & Fernandez, M. (2021) · Cells · doi:10.3390/cells10123604 · Cited by 71 · cited 1×
“Recent studies revealed that cells involved in the development and regression of liver fibrosis undergo metabolic reprogramming to meet their energy requirements [141–143].”
BackgroundMolecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Wang, F.-D., Zhou, J., & Chen, E.-Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 71 · cited 5×
“Autophagy drives HSC activation by fatty acids formed as a result of the cleavage of retinyl esters within lipid droplets [109,155].”
BackgroundInfluentialAntifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Brennan, P. N., Elsharkawy, A. M., Kendall, T. J., Loomba, R., Mann, D. A., & Fallowfield, J. A. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00796-x · Cited by 68 · cited 1×
“A key study published by Duffield et al. revealed macrophages as a source of MMPs by demonstrating that their depletion in mouse models influenced the level of fibrosis resolution [206].”
BackgroundFibrotic Events in the Progression of Cholestatic Liver Disease
Wu, H., Chen, C., Ziani, S., Nelson, L. J., Avila, M. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Cells · doi:10.3390/cells10051107 · Cited by 65 · cited 4×
“These findings have demonstrated that senescence of activated HSCs is a relevant mechanism in the eradication of HSCs in the context of liver fibrosis resolution [190,201].”
BackgroundInfluentialLian, N., Jiang, Y., Zhang, F., Jin, H., Lu, C., Wu, X., Lu, Y., & Zheng, S. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.59 · Cited by 64 · cited 1×
“During this process, LRAT expression is substantially reduced in activated HSCs, which causes a decrease in vitamin A storage and the progression of fibrosis [142,145–148].”
BackgroundThe role of liver sinusoidal cells in local hepatic immune surveillance
Wohlleber, D., & Knolle, P. A. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.74 · Cited by 64 · cited 2×
“In addition, they act as regional antigen-presenting cells (APCs) that govern, in addition to hepatic DCs and KCs, intrahepatic immune responses by secreting cytokines and by activating or inhibiting immune cell signaling pathways [114,115].”
BackgroundGracia‐Sancho, J., Manicardi, N., Ortega‐Ribera, M., Maeso‐Díaz, R., Guixé‐Muntet, S., Fernández‐Iglesias, A., Hide, D., García‐Calderó, H., Boyer‐Díaz, Z., Contreras, P. C., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1360 · Cited by 64 · cited 2×
“Exosomes, as communication vesicles released by all cell species in both physiological and pathological conditions, may also be involved in the regression of liver fibrosis [213].”
BackgroundEZH2‐mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis
Yang, Y., Chen, X., Li, W., Wu, X., Huang, C., Xie, J., Zhao, Y., Meng, X., & Li, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13153 · Cited by 62
Ding, Q., Xie, X.-L., Wang, M.-M., Yin, J., Tian, J.-M., Jiang, X.-Y., Zhang, D., Han, J., Bai, Y., Cui, Z.-J., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0199-6 · Cited by 60 · cited 10×
“The ECM production in activated HSCs that become senescent is reduced so that fibrogenesis decreases [187,191].”
BackgroundInfluentialKikuchi, A., Pradhan‐Sundd, T., Singh, S., Nagarajan, S., Loizos, N., & Monga, S. P. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.06.009 · Cited by 58 · cited 1×
“In HSCs, PDGFR-β activation induces their proliferation and migration, drives cell survival, and promotes the expression of hedgehog pathway ligands, such as sonic hedgehog, which triggers HSC activation [35,36].”
BackgroundPark, S. Y., Le, C. T., Sung, K. Y., Choi, D. H., & Cho, E.-H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.106 · Cited by 58 · cited 1×
“The metabolism of lipid droplets during HSC activation generates fatty acids for β -oxi dation [43,147–149].”
BackgroundHuang, T.-J., Ren, J.-J., Zhang, Q.-Q., Kong, Y.-Y., Zhang, H.-Y., Guo, X.-H., Fan, H.-Q., & Liu, L.-X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109034 · Cited by 55
Epigenetics as a versatile regulator of fibrosis
Liu, Y., Wen, D., Ho, C., Li, Y., Zheng, D., O’Reilly, S., Gao, Y., Li, Q., & Zhang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04018-5 · Cited by 55 · cited 2×
“Among several endogenous factors regulating gene expression, certain miRNAs are essential [161].”
BackgroundHepatic stellate cells and intralobular innervation in human liver cirrhosis
Ueno, T., Sata, M., Sakata, R., Torimura, T., Sakamoto, M., Sugawara, H., & Tanikawa, K. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90011-3 · Cited by 53 · cited 1×
“Differentiation of quiescent HSCs into activated HSCs is a two-step process: The initiation phase encompasses the priming of HSCs, which sensitizes them to fibrogenic and proliferative cytokines [41,47,48,53].”
BackgroundSmith-Cortinez, N., van Eunen, K., Heegsma, J., Serna-Salas, S. A., Sydor, S., Bechmann, L. P., Moshage, H., Bakker, B. M., & Faber, K. N. (2020) · Cells · doi:10.3390/cells9112456 · Cited by 52 · cited 2×
“TGF-β -induced autophagy displays a role in HSC activation through the c-jun N -terminal kinase and extracellular signal-regulated kinase signaling pathways [152].”
BackgroundNovel Therapeutic Targets in Liver Fibrosis
Zhang, J., Liu, Q., He, J., & Li, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.766855 · Cited by 51
High-Mobility Group Box 1 Protein Activates Hepatic Stellate Cells In Vitro
Kao, Y. H., Jawan, B., Goto, S., Hung, C.-T., Lin, Y., Nakano, T., Hsu, L., Lai, C.-Y., Tai, M., & Chen, C.-L. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.07.055 · Cited by 49 · cited 1×
“In addition, damaged hepatocytes may release nuclear HMGB1 and directly activate HSCs [66].”
BackgroundEvidence Against a Role for NADPH Oxidase Modulating Hepatic Vascular Tone in Cirrhosis
Gracia‐Sancho, J., Laviña, B., Rodríguez-Vilarrupla, A., Brandes, R. P., Fernández, M., Bosch, J., & García‐Pagán, J. C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.021 · Cited by 49 · cited 1×
“In experimental models of liver cirrhosis, liver endothelial KLF2 is upregulated as a compensatory mechanism driving the transcription of its vasoprotective target genes [124].”
BackgroundLambrecht, J., Verhulst, S., Mannaerts, I., Sowa, J., Best, J., Canbay, A. E., Reynaert, H., & van Grunsven, L. A. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.036 · Cited by 48 · cited 3×
“DNMT-mediated hypermethylation of phosphatase and tensin homolog (PTEN) initiates the activation of HSCs [39,49].”
BackgroundSelf-citationEpigenetic Changes during Hepatic Stellate Cell Activation
Götze, S., Schumacher, E. C., Kordes, C., & Häussinger, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128745 · Cited by 47 · cited 1×
“Although the transition of HSCs to myofibroblasts is associated with a general loss of DNA methylation, the presence of gene-specific DNA hypomethylation and hypermethylation has been documented in genome-wide DNA methylation studies [171,172].”
Background
Cited by
Tauil, R. B., Golono, P. T., de Lima, E. P., Goulart, R. D. Á., Guiguer, É. L., Bechara, M. D., Nicolau, C. C. T., Yanaguizawa, J. L., Fiorini, A. M. R., Méndez‐Sánchez, N., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17101354 · Cited by 85
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 79
“However, not all healthcare institutions have access to advanced imaging technologies like VCTE or MRE.”
BackgroundPuri, M., & Sonawane, S. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093988 · Cited by 41
“Furthermore, LSECs themselves become more susceptible to the effects of TGF-β , which contributes to their capillarization and loss of normal function [42].”
Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective
Zeng, X., Huang, D., Zhu, Z., Cai, Q., Yang, Y., Lu, H., & Chen, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1574385 · Cited by 36
Present and Future Perspectives in the Treatment of Liver Fibrosis
Cerrito, L., Galasso, L., Iaccarino, J., Pizzi, A., Termite, F., Esposto, G., Borriello, R., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2025) · Pharmaceuticals · doi:10.3390/ph18091321 · Cited by 35
“Conversely, hypomethylation of pro-fibrotic genes like TGF β 1 promotes sustained fibrogenic signaling, leading to continuous HSC activation and excessive ECM production [49–51].”
Metadata
- Authors
- Akkız, H., Gieseler, R. K., & Canbay, A.
- Affiliations
- Bahçeşehir University (TR)
- Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
- Corresponding author
- Akkız, Hikmet
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-07-18
- Volume
- 25
- Issue
- 14
- Pages
- 7873
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC11277292
- OpenAlex
- W4400775597
- Semantic Scholar
- 8810ad06f0650b984f245dec696c68e2f2723093
- Cited by
- 191
- References
- 223
- Citations by year
- 2026: 112 · 2025: 70 · 2024: 9
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, hepatic stellate cells, hepatic fibrogenesis, myofibroblast transdifferentiation, extracellular matrix deposition, hepatic stellate cell activation, HSC heterogeneity, macrophages, hepatocyte death, liver inflammation, antifibrotic therapy, cirrhosis reversal, cellular stress response, cytokines and chemokines
- MeSH terms
- Animals, Humans, Liver Cirrhosis, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.